Grown Rogue International (FRA:1VF0) EBIT: €2.29 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1VF0 Grown Rogue International Inc FRA:1VF0
49 GF Score
Price €0.36
GF Value €0.40
! 7 Warning Signs
View Full Analysis

What is Grown Rogue International EBIT?

Grown Rogue International FRA:1VF0 -8.67% 49 EBIT is €2.29 Mil as of Mar. 2026. GuruFocus rates FRA:1VF0 with a GF Score™ of 49/100 and a GF Value™ of €0.40. The stock has 7 warning signs investors should review.

Grown Rogue International's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €-0.99 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €2.29 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Grown Rogue International's annualized ROC % for the quarter that ended in Mar. 2026 was 0.82%. Grown Rogue International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -12.59%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Grown Rogue International's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 2.02%.


Grown Rogue International  (FRA:1VF0) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Grown Rogue International's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=0.344 * ( 1 - 0% )/( (42.145 + 42.012)/ 2 )
=0.344/42.0785
=0.82 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Grown Rogue International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-3.968/( ( (23.459 + max(7.805, 0)) + (25.545 + max(6.205, 0)) )/ 2 )
=-3.968/( ( 31.264 + 31.75 )/ 2 )
=-3.968/31.507
=-12.59 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.114 + 6.047 + 0.482) - (1.72 + 0 + 0.118)
=7.805

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.399 + 6.174 + 0.448) - (3.09 + 0 + 0.726)
=6.205

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Grown Rogue International's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=2.289/113.413
=2.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grown Rogue International EBIT Related Terms


Grown Rogue International EBIT Historical Data

* Premium members only.

The historical data trend for Grown Rogue International's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grown Rogue International EBIT Chart

Grown Rogue International Annual Data
Trend Aug16 Aug17 Aug18 Oct19 Oct20 Oct21 Oct22 Oct23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 1.58 1.05 -9.74 5.31

Grown Rogue International Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.51 1.94 2.12 -0.78 -0.99

FRA:1VF0 vs ZTS, UTHR: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grown Rogue International's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grown Rogue International EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grown Rogue International's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Grown Rogue International's EV-to-EBIT falls into.


FRA:1VF0
49GF Score
Grown Rogue International Inc FRA:1VF0
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grown Rogue International EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €2.29 Mil mean?
Grown Rogue International (FRA:1VF0) has a EBIT of €2.29 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Grown Rogue International.
Is Grown Rogue International's EBIT too high?
Grown Rogue International's current EBIT is €2.29 Mil. Overall, Grown Rogue International has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Grown Rogue International's EBIT compare to ZTS and UTHR?
Grown Rogue International's EBIT of €2.29 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Grown Rogue International. Grown Rogue International's current EBIT is €2.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grown Rogue International stock overvalued right now?
Grown Rogue International (FRA:1VF0) has a current EBIT of €2.29 Mil. The stock's GF Value™ is €0.40, compared to a current price of €0.36 — trading 10.5% below its estimated fair value. The current EBIT is €2.29 Mil. Grown Rogue International's overall GF Score™ is 49/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Grown Rogue International (FRA:1VF0), the current EBIT is €2.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grown Rogue International (FRA:1VF0) Overvalued in 2026?

Based on GuruFocus' analysis, Grown Rogue International stock appears to be undervalued. The current stock price of €0.36 is trading 10.5% below its estimated GF Value™ of €0.40.

Key valuation signals for FRA:1VF0:

  • EBIT: €2.29 Mil
  • GF Value™: €0.40 vs. price of €0.36 (10.5% below fair value)
  • GF Score™: 49/100 with 7 warning signs

No single metric tells the full story. See the FRA:1VF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Grown Rogue International Business Description

Other Exchanges GRUSF:USAGRIN:Canada
Address 550 Airport Road, Medford, OR, USA, 97504
Grown Rogue International Inc is engaged in the business of growing and selling cannabis products. Its primary cannabis product produced and sold is cannabis flower. Geographically, the company generates a majority of its revenue from the United States. The company has identified three operating segments: the Oregon segment represents cannabis production and sales activities in Oregon; the Michigan segment represents cannabis production and sales activities in Michigan; and the New Jersey segment represents cannabis production and sales activities in New Jersey.
49GF Score

Get the complete analysis for FRA:1VF0

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.36
Price
€0.40
GF Value